COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

1 Killed in Crash at E. Lynwood Drive and Mountain Avenue


2 Vehicles Collide Head-on in Fatal San Bernardino Accident

San Bernardino, CA (June 1, 2020) – One person was killed in a head-on crash in San Bernardino. The fatal accident occurred on the morning of June 1 at E. Lynwood Drive and Mountain Avenue.

Two vehicles collided head-on at the intersection. One vehicle was blocking the intersection, while the other ended up on the side of the road. One person was killed in the crash.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#San Bernardino

#92404


March 31, 2020

1 Killed in Crash on Interstate 15 Near Glen Helen Parkway

Pedestrian Hit by Car in Fatal San Bernardino Accident...


April 20, 2020

Teen Killed in Crash on Corning Road

Driver Loses Control in Fatal Rollover Accident in Corning...


April 30, 2020

1 Injured in Crash on 10 Freeway Near South Azusa Avenue

2 Vehicles Involved in West Covina Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.